Exploring DMT: Endogenous role and therapeutic potential

Area of Science:

• Neurobiology
• Biochemistry
• Pharmacology

Background:

• N,N-Dimethyltryptamine (DMT) is a naturally occurring psychedelic compound found across species.
• Previous studies underestimated endogenous DMT levels in mammals, but recent findings suggest significant concentrations and alternative synthesis pathways.
• This necessitates a re-evaluation of DMT's biological significance and endogenous functions.

Purpose of the Study:

• To evaluate the biosynthetic pathways of DMT, focusing on indolethylamine N-methyltransferase (INMT) and its isoforms.
• To investigate regulatory mechanisms, alternative synthesis routes, and the influence of physiological conditions (stress, hypoxia) on DMT levels.
• To examine the potential roles of endogenous DMT in neuroplasticity, neurogenesis, mitochondrial homeostasis, immunomodulation, and cellular protection.

Main Methods:

• Review of existing literature on DMT biosynthesis, focusing on INMT and related enzymes.
• Analysis of factors influencing DMT synthesis and degradation, including monoamine oxidase (MAO) activity.
• Examination of DMT's physicochemical properties and receptor interactions, including intracellular 5-HT2A activation.

Main Results:

• DMT's lipophilic nature facilitates cell membrane crossing and intracellular receptor activation, particularly 5-HT2A receptors.
• Endogenous DMT exhibits potential roles in neuroplasticity, neurogenesis, mitochondrial function, immune response, and protection against oxidative stress and hypoxia.
• The widespread presence of DMT pathways suggests crucial roles in development and adaptation.

Conclusions:

• Endogenous DMT may function as a neurotransmitter or neuromodulator, acting through both traditional and intracellular pathways.
• DMT's diverse physiological roles suggest significant neurobiological importance and potential clinical applications.
• Further research is warranted to fully elucidate the functions of endogenous DMT.